Inventor
SAMARTH KULKARNI
Inventor
US
Overview
Patents· 9 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C12Nprimary
C12NMicroorganisms or enzymes31%
A61KPreparations for medical, dental or toiletry purposes28%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations17%
C07KPeptides17%
C12YEnzymes7%
PatentTitleYear
12,442,020Materials and methods for treatment of pain related disorders202511,920,148Compositions and methods for gene editing202411,801,313Materials and methods for treatment of pain related disorders202311,564,997Materials and methods for treatment of friedreich ataxia and other related disorders202311,559,588Materials and methods for treatment of Spinocerebellar Ataxia Type 1 (SCA1) and other Spinocerebellar Ataxia Type 1 Protein (ATXN1) gene related conditions or disorders202311,459,587Materials and methods for treatment of pain related disorders202211,427,838Materials and methods for treatment of myotonic dystrophy type 1 (DM1) and other related disorders202211,407,997Materials and methods for treatment of primary hyperoxaluria type 1 (PH1) and other alanine-glyoxylate aminotransferase (AGXT) gene related conditions or disorders202211,174,469Materials and methods for treatment of Amyotrophic Lateral Sclerosis (ALS) and other related disorders2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2024Patents assigned to CRISPR THERAPEUTICS AG (5)· patent assignee history
2021–2025Based in US· patent location history
2022–2025Patents assigned to VERTEX PHARMA (4)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| CRISPR THERAPEUTICS AG | 5 | 2021–2024 |
| VERTEX PHARMA | 4 | 2022–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 9 | 2021–2025 |